Focuses on Frontline Metastatic Pancreatic Cancer | Patients Get Added Benefits of Investigational Agents - 102191

Spotlight
Video

Focuses on Frontline Metastatic Pancreatic Cancer | Patients Get Added Benefits of Investigational Agents

Cancer-News has 158 videos Subscribe Here

Loading........
Description: Ramy Ibrahim, M.D., Parker Institute for Cancer Immunotherapy, explains that the study Focuses on Frontline Metastatic Pancreatic Cancer | Patients Get Added Benefits of Investigational Agents.
Shared By : Cancer-News
Posted on : 07/26/18
Added : 5 months ago
Category : Pancreatic Cancer